This page is part of the FHIR Specification (v4.2.0: R5 Preview #1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3 R2
Pharmacy Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Not linked to any defined compartments |
Raw XML (canonical form + also see XML Format Specification)
Oral Chemotherapy Example - Manufactured Product - Xeloda - includes a reference to a substance in ingredient element (id = "medexample015")
<?xml version="1.0" encoding="UTF-8"?> <Medication xmlns="http://hl7.org/fhir"> <id value="medexample015"/> <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"><p> <b> Generated Narrative with Details</b> </p> <p> <b> id</b> : medexample015</p> <p> <b> contained</b> : , </p> <p> <b> code</b> : Capecitabine 500mg oral tablet (Xeloda) <span> (Details : {RxNorm code '213293' = 'Xeloda 500 MG Oral Tablet', given as 'Capecitabine 500mg oral tablet (Xeloda)'})</span> </p> <p> <b> manufacturer</b> : id: org2; name: Gene Inc</p> <p> <b> doseForm</b> : Tablet dose form (qualifier value) <span> (Details : {SNOMED CT code '385055001' = 'Tablet', given as 'Tablet dose form (qualifier value)'})</span> </p> <h3> Ingredients</h3> <table> <tr> <td> -</td> <td> <b> Item[x]</b> </td> <td> <b> Strength[x]</b> </td> </tr> <tr> <td> *</td> <td> id: sub04; Capecitabine (substance) <span> (Details : {SNOMED CT code '386906001' = 'Capecitabine', given as 'Capecitabine (substance)'})</span> </td> <td> 500 mg<span> (Details: UCUM code mg = 'mg')</span> /1 TAB<span> (Details: http://terminology.hl7.org/CodeSystem/v3-orderableDrugForm code TAB = 'Tablet')</span> </td> </tr> </table> <h3> Batches</h3> <table> <tr> <td> -</td> <td> <b> LotNumber</b> </td> <td> <b> ExpirationDate</b> </td> </tr> <tr> <td> *</td> <td> 9494788</td> <td> 2017-05-22</td> </tr> </table> </div> </text> <contained> <Organization> <id value="org2"/> <name value="Gene Inc"/> </Organization> </contained> <contained> <Substance> <id value="sub04"/> <code> <coding> <system value="http://snomed.info/sct"/> <code value="386906001"/> <display value="Capecitabine (substance)"/> </coding> </code> </Substance> </contained> <code> <coding> <system value="http://www.nlm.nih.gov/research/umls/rxnorm"/> <code value="213293"/> <display value="Capecitabine 500mg oral tablet (Xeloda)"/> </coding> </code> <manufacturer> <reference value="#org2"/> </manufacturer> <doseForm> <coding> <system value="http://snomed.info/sct"/> <code value="385055001"/> <display value="Tablet dose form (qualifier value)"/> </coding> </doseForm> <ingredient> <itemReference> <reference value="#sub04"/> </itemReference> <strengthRatio> <numerator> <value value="500"/> <system value="http://unitsofmeasure.org"/> <code value="mg"/> </numerator> <denominator> <value value="1"/> <system value="http://terminology.hl7.org/CodeSystem/v3-orderableDrugForm"/> <code value="TAB"/> </denominator> </strengthRatio> </ingredient> <batch> <lotNumber value="9494788"/> <expirationDate value="2017-05-22"/> </batch> </Medication>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.